Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to sign up for SAGE Journal Email Alerts today!

Sign In to gain access to subscriptions and/or personal tools.
Medical Decision Making
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Jansen, S. J. T.
Right arrow Articles by Stiggelbout, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jansen, S. J. T.
Right arrow Articles by Stiggelbout, A. M.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Breast Cancer
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Stability of Patients’ Preferences for Chemotherapy

The Impact of Experience

Sylvia J. T. Jansen, PhD

Department of Clinical Oncology, Department of Medical Decision Making, Leiden University Medical Center, Leiden, the Netherlands

Job Kievit, MD, PhD

Department of Medical Decision Making, Leiden University Medical Center, Leiden, the Netherlands

Marianne A. Nooij, MD

Department of Clinical Oncology, Leiden University Medical Center, Leiden, the Netherlands

Anne M. Stiggelbout, PhD

Department of Medical Decision Making, Leiden University Medical Center, Leiden, the Netherlands

Background. Studies have shown that utilities for a particular treatment, elicited by means of a hypothetical treatment scenario, may remain stable within the same patients when examined before, during, and after experiencing that treatment (within-group stability). However, other studies have found that utilities for a particular health state may differ between patient groups who are and who are not experiencing the particular health state (between-group differences). Objective. The authors evaluated this apparent contradiction in the case of adjuvant chemotherapy for breast cancer. A related purpose was to examine whether a chemotherapy scenario adequately reflects the patients’ own experiences with chemotherapy. Method. Forty-three patients with early-stage breast cancer evaluated their actually experienced health state and a chemotherapy scenario before, during, and after undergoing adjuvant chemotherapy (chemotherapy group). A control group of 51 patients for whom chemotherapy was not part of the treatment plan was interviewed at similar points in time. Utilities were elicited by means of a visual analog scale (VAS), a chained time trade-off (TTO), and a chained standard gamble (SG). Results. The utilities for the chemotherapy scenario remained relatively stable over time in the 2 patient groups. Furthermore, the chemotherapy scenario was evaluated more positively by patients in the chemotherapy group than by control patients (e.g., utilities before chemotherapy: VAS 0.69 vs. 0.50, TTO 0.88 vs.0.50, SG 0.92 vs. 0.58, all Ps < 0.01). Finally, patients in the chemotherapy group evaluated their actually experienced health states during chemotherapy higher than the chemotherapy scenario that was assessed at the same time (VAS 0.79 vs. 0.69, TTO 0.93 vs. 0.87, SG 0.97 vs. 0.96, all Ps < 0.05). Conclusions. Both within-group stability and between-group differences were found. A possible explanation for within-group stability may be that the chemotherapy scenario did not fully correspond to the patients’ actual experiences with chemotherapy ("noncorresponding description"). Therefore, preferences did not change even when the patients’ own clinical health status had changed. The between-group differences may be explained by "anticipated adaptation." Both explanations may work together to explain why utilities remain stable within the same patients but differ between different patient groups.

Key Words: stability • utility assessment • standard gamble • time trade-off

Medical Decision Making, Vol. 21, No. 4, 295-306 (2001)
DOI: 10.1177/0272989X0102100405


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Arch Intern MedHome page
M. N. Wittink, K. H. Morales, L. A. Meoni, D. E. Ford, N.-y. Wang, M. J. Klag, and J. J. Gallo
Stability of Preferences for End-of-Life Treatment After 3 Years of Follow-up: The Johns Hopkins Precursors Study
Arch Intern Med, October 27, 2008; 168(19): 2125 - 2130.
[Abstract] [Full Text] [PDF]


Home page
AM J HOSP PALLIAT CAREHome page
J. E. Rohrer, S. H. Lim, and F. A. Bock
Medical Condition Is Related to Treatment Preference in Cancer Patients: Implications for Quality Assessment
American Journal of Hospice and Palliative Medicine, February 1, 2007; 24(1): 36 - 41.
[Abstract] [PDF]


Home page
Med Decis MakingHome page
O. Kostopoulou
The Transient Nature of Utilities and Health Preferences
Med Decis Making, July 1, 2006; 26(4): 304 - 306.
[PDF]


Home page
Med Decis MakingHome page
J. H. Goldberg
Being There Is Important, but Getting There Matters Too: The Role of Path in the Valuation Process
Med Decis Making, July 1, 2006; 26(4): 323 - 337.
[Abstract] [PDF]


Home page
ptjournalHome page
M.-R. Lin, H.-F. Hwang, K.-P. Chung, C. Huang, and C.-Y. Chen
Rating Scale, Standard Gamble, and Time Trade-off for People With Traumatic Spinal Cord Injuries
Physical Therapy, March 1, 2006; 86(3): 337 - 344.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
K. R. Yabroff, W. F. Lawrence, S. Clauser, W. W. Davis, and M. L. Brown
Burden of Illness in Cancer Survivors: Findings From a Population-Based National Sample
J Natl Cancer Inst, September 1, 2004; 96(17): 1322 - 1330.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
S. J.T. Jansen, W. Otten, and A. M. Stiggelbout
Review of Determinants of Patients' Preferences for Adjuvant Therapy in Cancer
J. Clin. Oncol., August 1, 2004; 22(15): 3181 - 3190.
[Abstract] [Full Text] [PDF]


Home page
Dentomaxillofac RadiolHome page
P. Mileman and W. van den Hout
Preferences for oral health states: effect on prescribing periapical radiographs
Dentomaxillofac. Radiol., November 1, 2003; 32(6): 401 - 407.
[Abstract] [Full Text] [PDF]


Home page
Med Decis MakingHome page
J. Baron, D. A. Asch, A. Fagerlin, C. Jepson, G. Loewenstein, J. Riis, M. G. Stineman, and P. A. Ubel
Effect of Assessment Method on the Discrepancy between Judgments of Health Disorders People have and do not have: A Web Study
Med Decis Making, September 1, 2003; 23(5): 422 - 434.
[Abstract] [PDF]


Home page
Arch Pediatr Adolesc MedHome page
S. Saigal, B. L. Stoskopf, E. Burrows, D. L. Streiner, and P. L. Rosenbaum
Stability of Maternal Preferences for Pediatric Health States in the Perinatal Period and 1 Year Later
Arch Pediatr Adolesc Med, March 1, 2003; 157(3): 261 - 269.
[Abstract] [Full Text] [PDF]